Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Southwest Airlines
LUV
$22.3B
| $31.9M | 0.07% |
+1,187,780
| New | +$29.9M |
|
302
MarketAxess Holdings
MKTX
$5.72B
| $31.8M | 0.07% |
588,410
+87,900
| +18% | +$4.8M |
|
|
SLXP
303
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $31.8M | 0.07% |
257,819
+167,685
| +186% | +$18.5M |
|
|
DCT
304
DELISTED
DCT Industrial Trust Inc.
DCT
| $31.7M | 0.07% |
964,400
-238,050
| -20% | -$7.52M |
|
305
Toronto Dominion Bank
TD
$201B
| $31.6M | 0.07% |
613,880
+123,800
| +25% | +$6.01M |
|
|
CHS
306
DELISTED
Chicos FAS, Inc.
CHS
| $31.3M | 0.07% |
1,842,700
-633,800
| -26% | -$10.2M |
|
|
CKEC
307
DELISTED
Carmike Cinemas Inc
CKEC
| $31.2M | 0.07% |
889,000
+34,500
| +4% | +$1.12M |
|
|
SYNT
308
DELISTED
Syntel Inc
SYNT
| $31.2M | 0.07% |
726,190
+83,200
| +13% | +$3.42M |
|
309
CenterPoint Energy
CNP
$26.5B
| $31.1M | 0.07% |
+1,218,200
| New | +$29.5M |
|
|
SEMG
310
DELISTED
SEMGROUP CORPORATION
SEMG
| $31M | 0.07% |
393,600
-180,901
| -31% | -$12.3M |
|
311
Clorox
CLX
$13.1B
| $30.9M | 0.07% |
338,500
-432,700
| -56% | -$38.8M |
|
|
CYS
312
DELISTED
CYS Investments Inc.
CYS
| $30.9M | 0.07% |
3,425,500
+2,692,207
| +367% | +$23.8M |
|
313
Expeditors International
EXPD
$23B
| $30.8M | 0.07% |
698,316
-553,700
| -44% | -$23.8M |
|
314
Ford
F
$55.7B
| $30.8M | 0.07% |
+1,785,209
| New | +$29M |
|
315
Telephone and Data Systems
TDS
$3.84B
| $30.6M | 0.07% |
1,170,892
-485,400
| -29% | -$12.9M |
|
|
MWE
316
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $30.3M | 0.07% |
+423,445
| New | +$27.3M |
|
|
OCR
317
DELISTED
OMNICARE INC
OCR
| $30.3M | 0.07% |
454,900
-27,400
| -6% | -$1.7M |
|
318
EnerSys
ENS
$6.79B
| $30.3M | 0.07% |
439,800
+329,979
| +300% | +$22.4M |
|
319
TC Energy
TRP
$66.3B
| $30M | 0.07% |
628,803
+55,827
| +10% | +$2.61M |
|
|
EGN
320
DELISTED
Energen
EGN
| $30M | 0.07% |
+337,600
| New | +$28.4M |
|
|
ECOL
321
DELISTED
US Ecology, Inc.
ECOL
| $29.8M | 0.07% |
609,144
-11,007
| -2% | -$505K |
|
|
ESRX
322
DELISTED
Express Scripts Holding Company
ESRX
| $29.5M | 0.07% |
+425,639
| New | +$30M |
|
323
Equifax
EFX
$21.4B
| $29.3M | 0.07% |
403,500
-114,300
| -22% | -$8.02M |
|
324
Groupon
GRPN
$889M
| $29.2M | 0.07% |
+220,660
| New | +$29.1M |
|
325
Pembina Pipeline
PBA
$28.3B
| $29.2M | 0.07% |
678,300
+92,900
| +16% | +$3.72M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.